NL164272C - Werkwijze voor het bereiden van een farmaceutisch of veterinair preparaat op basis van prostaglandine f&012alfa- of e&012-analoga, door toepassing daarvan verkregen, gevormd preparaat, alsmede werkwijze voor de bereiding van daarvoor geschikte verbindingen. - Google Patents
Werkwijze voor het bereiden van een farmaceutisch of veterinair preparaat op basis van prostaglandine f&012alfa- of e&012-analoga, door toepassing daarvan verkregen, gevormd preparaat, alsmede werkwijze voor de bereiding van daarvoor geschikte verbindingen.Info
- Publication number
- NL164272C NL164272C NL7206361.A NL7206361A NL164272C NL 164272 C NL164272 C NL 164272C NL 7206361 A NL7206361 A NL 7206361A NL 164272 C NL164272 C NL 164272C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- preparing
- 012alfa
- prostaglandine
- analogs
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 4
- 238000004519 manufacturing process Methods 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/535—Organo-phosphoranes
- C07F9/5352—Phosphoranes containing the structure P=C-
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1413971 | 1971-05-11 | ||
| GB3967272A GB1348036A (en) | 1970-05-15 | 1972-01-05 | Transistorized vertical deflection circuit |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7206361A NL7206361A (de) | 1972-11-14 |
| NL164272B NL164272B (nl) | 1980-07-15 |
| NL164272C true NL164272C (nl) | 1980-12-15 |
Family
ID=26235892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7206361.A NL164272C (nl) | 1971-05-11 | 1972-05-10 | Werkwijze voor het bereiden van een farmaceutisch of veterinair preparaat op basis van prostaglandine f&012alfa- of e&012-analoga, door toepassing daarvan verkregen, gevormd preparaat, alsmede werkwijze voor de bereiding van daarvoor geschikte verbindingen. |
Country Status (26)
| Country | Link |
|---|---|
| JP (1) | JPS5611699B1 (de) |
| AR (4) | AR194952A1 (de) |
| AT (4) | AT328103B (de) |
| AU (1) | AU462755B2 (de) |
| BE (1) | BE783292A (de) |
| CA (1) | CA1077033A (de) |
| CH (3) | CH596165A5 (de) |
| CS (1) | CS192456B2 (de) |
| DD (1) | DD99155A5 (de) |
| DE (1) | DE2223365C3 (de) |
| DK (1) | DK134598B (de) |
| EG (1) | EG10752A (de) |
| ES (1) | ES402627A1 (de) |
| FI (1) | FI63221C (de) |
| FR (1) | FR2137712A1 (de) |
| HK (1) | HK50176A (de) |
| HU (1) | HU166717B (de) |
| IE (1) | IE37602B1 (de) |
| IL (1) | IL39376A (de) |
| KE (1) | KE2634A (de) |
| NL (1) | NL164272C (de) |
| NO (1) | NO139521C (de) |
| SE (4) | SE399705B (de) |
| SU (1) | SU662007A3 (de) |
| YU (1) | YU35876B (de) |
| ZM (1) | ZM8172A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4304907A (en) * | 1972-05-10 | 1981-12-08 | The Upjohn Company | Bicyclo lactone intermediates for prostaglandin analogs |
| DD118856A5 (de) * | 1972-11-08 | 1976-03-20 | ||
| US3966795A (en) * | 1973-05-21 | 1976-06-29 | The Upjohn Company | 5-Oxa-11-deoxyphenyl- and phenoxy-substituted prostaglandin F1.sub.α analogs |
| US3968144A (en) * | 1973-05-21 | 1976-07-06 | The Upjohn Company | 5-Oxa-11-deoxy phenyl- and phenoxy-substituted prostalandin E1 analogs |
| US4387241A (en) * | 1974-11-01 | 1983-06-07 | American Cyanamid Company | Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives |
| US4149006A (en) * | 1977-01-24 | 1979-04-10 | G. D. Searle & Co. | Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain |
| US4191774A (en) * | 1978-01-18 | 1980-03-04 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | Novel 17-aza-PGF2α derivatives and pharmaceutical compositions containing the same |
| US4228296A (en) * | 1979-01-24 | 1980-10-14 | American Cyanamid Company | Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives |
| US4929740A (en) * | 1984-10-09 | 1990-05-29 | Syntex (U.S.A.) Inc. | Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives |
| CS264861B1 (en) * | 1986-12-12 | 1989-09-12 | Kral Josef | Agent for cow natality increase |
| CS265947B1 (en) * | 1987-06-16 | 1989-11-14 | Kral Josef | Means for farming animals' ovarian functions control |
| US5565492A (en) * | 1988-07-18 | 1996-10-15 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| CS276003B6 (en) * | 1988-09-28 | 1992-03-18 | Spolana | method of production of (+)-isomer of cloprostenol |
| US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
| US6531504B2 (en) * | 2001-05-17 | 2003-03-11 | Allergan, Inc. | Prostanoic acid derivatives as agents for lowering intraocular pressure |
| CN102977048A (zh) * | 2007-11-09 | 2013-03-20 | 阿勒根公司 | 具有前列腺素活性的取代环戊烷 |
-
1972
- 1972-04-27 IE IE557/72A patent/IE37602B1/xx unknown
- 1972-04-28 CA CA140,884A patent/CA1077033A/en not_active Expired
- 1972-05-04 HU HUIE502A patent/HU166717B/hu unknown
- 1972-05-08 IL IL39376A patent/IL39376A/xx unknown
- 1972-05-08 ZM ZM81/72*UA patent/ZM8172A1/xx unknown
- 1972-05-08 AU AU42024/72A patent/AU462755B2/en not_active Expired
- 1972-05-09 EG EG193/72A patent/EG10752A/xx active
- 1972-05-09 NO NO1648/72A patent/NO139521C/no unknown
- 1972-05-09 SE SE7206139A patent/SE399705B/xx unknown
- 1972-05-10 BE BE783292A patent/BE783292A/xx not_active IP Right Cessation
- 1972-05-10 CH CH1566676A patent/CH596165A5/xx not_active IP Right Cessation
- 1972-05-10 CH CH697472A patent/CH590223A5/xx not_active IP Right Cessation
- 1972-05-10 NL NL7206361.A patent/NL164272C/xx not_active IP Right Cessation
- 1972-05-10 ES ES402627A patent/ES402627A1/es not_active Expired
- 1972-05-10 DK DK236272AA patent/DK134598B/da unknown
- 1972-05-10 FI FI1333/72A patent/FI63221C/fi active
- 1972-05-10 CH CH1566776A patent/CH596166A5/xx not_active IP Right Cessation
- 1972-05-10 SU SU721787999A patent/SU662007A3/ru active
- 1972-05-10 FR FR7216685A patent/FR2137712A1/fr active Granted
- 1972-05-11 YU YU1250/72A patent/YU35876B/xx unknown
- 1972-05-11 JP JP4684472A patent/JPS5611699B1/ja active Pending
- 1972-05-11 AR AR241955A patent/AR194952A1/es active
- 1972-05-11 CS CS723161A patent/CS192456B2/cs unknown
- 1972-05-11 DD DD162906A patent/DD99155A5/xx unknown
- 1972-05-12 DE DE2223365A patent/DE2223365C3/de not_active Expired
- 1972-05-12 AT AT538973*7A patent/AT328103B/de not_active IP Right Cessation
- 1972-05-12 AT AT419172A patent/AT333447B/de not_active IP Right Cessation
- 1972-11-30 AR AR245418A patent/AR197100A1/es active
- 1972-11-30 AR AR245420A patent/AR200484A1/es active
- 1972-11-30 AR AR245419A patent/AR197101A1/es active
-
1973
- 1973-05-12 AT AT539173*7A patent/AT328105B/de not_active IP Right Cessation
- 1973-05-12 AT AT539073*7A patent/AT328104B/de not_active IP Right Cessation
-
1975
- 1975-04-15 SE SE7504337A patent/SE7504337L/xx unknown
- 1975-04-15 SE SE7504336A patent/SE7504336L/xx unknown
- 1975-04-15 SE SE7504335A patent/SE7504335L/xx unknown
-
1976
- 1976-05-31 KE KE2634*UA patent/KE2634A/xx unknown
- 1976-08-05 HK HK501/76*UA patent/HK50176A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL149153B (nl) | Werkwijze voor de bereiding van 1,3-butadieen en methacroleine. | |
| NL164272C (nl) | Werkwijze voor het bereiden van een farmaceutisch of veterinair preparaat op basis van prostaglandine f&012alfa- of e&012-analoga, door toepassing daarvan verkregen, gevormd preparaat, alsmede werkwijze voor de bereiding van daarvoor geschikte verbindingen. | |
| NL170147C (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat, gevormd preparaat daarvan en heterocyclische diaminen hiervoor. | |
| NL7514940A (nl) | Werkwijze voor het bereiden van azolyl-1 methanen en de zouten daarvan, alsmede de toe- passing daarvan als geneesmiddelen. | |
| NL167151C (nl) | Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen. | |
| NL166939C (nl) | Werkwijze voor het bereiden van geneesmiddelen met een gunstige invloed op de bloedsomloop, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve verbindingen. | |
| FI49503C (fi) | Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi. | |
| NL156404B (nl) | Werkwijze voor de bereiding van chromanderivaten. | |
| NL159981B (nl) | Werkwijze voor de bereiding van oxabicycloalkenen. | |
| NL148602B (nl) | Werkwijze voor het bereiden van een farmaceutisch preparaat waarin op de 5-plaats gesubstitueerde 1-alkyl-2-nitro-imidazoolderivaten zijn opgenomen, alsmede gevormd preparaat en werkwijze voor het bereiden van deze verbindingen. | |
| NL160250C (nl) | Werkwijze voor het bereiden van prostaglandinen van de "een" reeks. | |
| NL170529C (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat op basis van een 3-alkoxy-1-aryloxypropanol-2 en werkwijze voor de bereiding van de daarbij te gebruiken verbindingen. | |
| NL7501430A (nl) | Werkwijze voor het bereiden van aminodihydro- inen, werkwijze voor het bereiden van ge- iddelen alsmede gevormde geneesmiddelen. | |
| NL176252C (nl) | Werkwijze voor de bereiding van 1,4-diacetoxybutaan. | |
| NL161150B (nl) | Werkwijze voor het bereiden van een geneesmiddel, alsmede verkregen gevormd geneesmiddel en werkwijze voor het bereiden van een benzofuranverbinding. | |
| NL169314C (nl) | Werkwijze voor de bereiding van een geneesmiddel met bronchodilatoractiviteit, gevormd geneesmiddel verkregen volgens deze werkwijze en werkwijze voor de bereiding van geneeskrachtige verbindingen ten gebruike daarbij. | |
| NL171888C (nl) | Werkwijze voor de bereiding van cyclododecatrieen-(1.5.9.). | |
| NL154514B (nl) | Werkwijze voor het bereiden van een lokaal werkzaam geneesmiddel voor de huid en slijmvliezen op basis van een steroideverbinding, alsmede gevormd geneesmiddel en werkwijze voor het bereiden van de actieve verbindingen. | |
| NL181358C (nl) | Werkwijze voor de bereiding van 3,6-dichloorpicolinezuur. | |
| NL171163C (nl) | Werkwijze voor de bereiding van polyimideharsen, alsmede geheel of ten dele daaruit bestaand gevormd voortbrengsel. | |
| NL160258B (nl) | Werkwijze voor de bereiding van 2,3-dihydrobenzodia- zepinen. | |
| NL7411179A (nl) | Werkwijze voor het bereiden van nieuwe china- zolinen of de zuuradditiezouten ervan, alsmede de daarmee bereide farmaceutische preparaten. | |
| NL159108B (nl) | Werkwijze voor de bereiding van cyclische dicarboximidofosfonothioaten. | |
| NL155823B (nl) | Werkwijze voor het bereiden van 2,4,6,2',4',6'-hexanitrodifenylamine. | |
| NL7415113A (nl) | Werkwijze voor de bereiding van chinoxaline- -n,n'-dioxyden. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| V4 | Discontinued because of reaching the maximum lifetime of a patent |